HIMS HERS HEALTH INC

NYSE: HIMS (Hims & Hers Health, Inc.)

Last update: 5 days ago, 11:24AM

53.55

0.30 (0.56%)

Previous Close 53.25
Open 52.12
Volume 10,882,275
Avg. Volume (3M) 31,841,820
Market Cap 12,103,348,224
Price / Earnings (TTM) 67.78
Price / Earnings (Forward) 81.97
Price / Sales 7.15
Price / Book 23.46
52 Weeks Range
16.05 (-70%) — 72.98 (36%)
Earnings Date 3 Nov 2025
Profit Margin 9.21%
Operating Margin (TTM) 10.12%
Diluted EPS (TTM) 0.680
Quarterly Revenue Growth (YOY) 110.70%
Quarterly Earnings Growth (YOY) 344.70%
Total Debt/Equity (MRQ) 11.54%
Current Ratio (MRQ) 1.59
Operating Cash Flow (TTM) 334.34 M
Levered Free Cash Flow (TTM) 213.45 M
Return on Assets (TTM) 10.76%
Return on Equity (TTM) 36.79%

Market Trend

Short Term Medium Term
Industry Household & Personal Products (US) Bearish Bearish
Household & Personal Products (Global) Bearish Bearish
Stock Hims & Hers Health, Inc. Bullish Bullish

AIStockmoo Score

-0.6
Analyst Consensus -1.5
Insider Activity -5.0
Price Volatility -0.5
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average -0.60

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
HIMS 12 B - 67.78 23.46
ELF 7 B - 76.79 9.08
PG 357 B 1.32% 23.43 6.99
UL 150 B 1.54% 23.39 6.96
CL 66 B 1.23% 22.79 91.63
KMB 41 B 4.06% 16.70 32.32

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Sector Consumer Defensive
Industry Household & Personal Products
Investment Style Small Growth
% Held by Insiders 11.13%
% Held by Institutions 82.47%

Ownership

Name Date Shares Held
Srs Investment Management, Llc 30 Jun 2025 4,000,000
52 Weeks Range
16.05 (-70%) — 72.98 (36%)
Price Target Range
37.00 (-30%) — 68.00 (26%)
High 68.00 (Canaccord Genuity, 26.98%) Buy
Median 52.50 (-1.96%)
Low 37.00 (Truist Securities, -30.91%) Hold
Average 52.50 (-1.96%)
Total 1 Buy, 1 Hold
Avg. Price @ Call 50.30
Firm Date Target Price Call Price @ Call
Canaccord Genuity 12 Sep 2025 68.00 (26.98%) Buy 55.50
Truist Securities 18 Aug 2025 37.00 (-30.91%) Hold 45.10
17 Jul 2025 48.00 (-10.36%) Hold 49.99
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BECKLUND IRENE - 50.35 -8,410 -423,444
BOUGHTON SOLEIL - 50.35 -2,637 -132,773
CARROLL PATRICK HARRISON - 50.35 -10,021 -504,557
CHI MICHAEL - 50.35 -13,749 -692,262
DUDUM ANDREW - 50.71 -240,771 -12,217,677
OKUPE OLUYEMI - 57.70 -23,584 -1,360,797
Aggregate Net Quantity -299,172
Aggregate Net Value ($) -15,331,510
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 51.40
Name Holder Date Type Quantity Price Value ($)
OKUPE OLUYEMI Officer 22 Sep 2025 Automatic sell (-) 23,584 57.70 1,360,797
CHI MICHAEL Officer 17 Sep 2025 Automatic sell (-) 13,749 50.35 692,262
DUDUM ANDREW Officer 17 Sep 2025 Automatic sell (-) 65,110 50.35 3,278,289
CARROLL PATRICK HARRISON Officer 17 Sep 2025 Automatic sell (-) 10,021 50.35 504,557
BECKLUND IRENE Officer 17 Sep 2025 Automatic sell (-) 8,410 50.35 423,444
BOUGHTON SOLEIL Officer 17 Sep 2025 Automatic sell (-) 2,637 50.35 132,773
DUDUM ANDREW Officer 16 Sep 2025 Automatic sell (-) 47,534 50.89 2,419,005
DUDUM ANDREW Officer 16 Sep 2025 Automatic sell (-) 128,127 50.89 6,520,383
DUDUM ANDREW Officer 16 Sep 2025 Option execute 125,335 - -
Date Type Details
10 Sep 2025 Announcement Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
26 Aug 2025 TheFinance 4 Attractive US Growth Stocks Set to Sizzle Up Your Investment Portfolio
25 Aug 2025 Announcement SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
22 Aug 2025 Announcement Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained
21 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
21 Aug 2025 Announcement Investors SueWallSt as Hims & Hers Health, Inc. Faces Securities Fraud Allegations
20 Aug 2025 Announcement Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained
19 Aug 2025 Announcement SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
19 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
18 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
14 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
13 Aug 2025 Announcement SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
11 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
07 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
05 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
04 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
04 Aug 2025 Announcement Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
31 Jul 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
29 Jul 2025 Announcement Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care
29 Jul 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
14 Jul 2025 Announcement Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
09 Jul 2025 Announcement Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
09 Jul 2025 CNBC Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
08 Jul 2025 Announcement INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims & Hers Health Inc. to Contact Law Firm
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria